ACADIA PHARMACEUTICALS INC. - US0042251084 (Stock)
Nasdaq
| Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
|---|---|---|---|---|---|---|
24,60 USD
|
0,8197% | 08.08.2025 22:00 | 100,00 | 24,27 | 25,26 | 100,00 |
| Contact | |
|---|---|
|
ACADIA Pharmaceuticals Inc. Sorrento Valley Blvd. 92121, San Diego, CA, US |
| Phone | +1 (858) 558-2871 |
| Fax | +1 (858) 558-2872 |
| info@acadia-pharm.com | |
| Internet | http://www.acadia-pharm.com |
| IR Contact/PR Contact | -/- |
| Symbol | |
| End of financial year | 31.12.2025 |
| Issued capital | 3.526.033.969,89 EUR |
| Shareholders |
|---|
| Board | |
|---|---|
| Dr. Stephen Biggar | Chairman of Board of Directors |
| Dr. Edmund Harrigan | Member of Board of Directors |
| Dr. Elizabeth Garofalo | Member of Board of Directors |
| James Daly | Member of Board of Directors |
| Julian Baker | Member of Board of Directors |
| Laura Brege | Member of Board of Directors |
| Dr. Adora Ndu | Member of Board of Directors |
| Daniel Soland | Member of Board of Directors |
| Activity Description |
|---|
| - |
© 2000 - 2025 UniCredit Bank Austria AG. Please read our terms and conditions
Implemented and powered by FactSet
Fond data is provided from Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
